Market Closed -
Nasdaq Stockholm
12:00:00 2024-07-12 pm EDT
|
5-day change
|
1st Jan Change
|
72.3
SEK
|
+3.29%
|
|
+0.14%
|
+21.31%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,921
|
875.3
|
2,023
|
2,480
|
-
|
-
|
Enterprise Value (EV)
1 |
1,921
|
875.3
|
2,280
|
2,480
|
2,480
|
2,480
|
P/E ratio
|
23.2
x
|
13.1
x
|
12.6
x
|
13.5
x
|
11.7
x
|
10.4
x
|
Yield
|
-
|
-
|
5.03%
|
2.77%
|
2.42%
|
4.15%
|
Capitalization / Revenue
|
-
|
0.61
x
|
1.15
x
|
1.22
x
|
1.1
x
|
1.04
x
|
EV / Revenue
|
-
|
0.61
x
|
1.15
x
|
1.22
x
|
1.1
x
|
1.04
x
|
EV / EBITDA
|
-
|
7.81
x
|
8.41
x
|
9.43
x
|
8.3
x
|
7.45
x
|
EV / FCF
|
-
|
-
|
8.64
x
|
11.5
x
|
12
x
|
9.92
x
|
FCF Yield
|
-
|
-
|
11.6%
|
8.71%
|
8.35%
|
10.1%
|
Price to Book
|
-
|
-
|
7.78
x
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
33,702
|
33,861
|
33,942
|
34,308
|
-
|
-
|
Reference price
2 |
57.00
|
25.85
|
59.60
|
72.30
|
72.30
|
72.30
|
Announcement Date
|
2/28/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,443
|
1,766
|
2,040
|
2,245
|
2,389
|
EBITDA
1 |
-
|
112.1
|
240.6
|
263
|
299
|
333
|
EBIT
1 |
-
|
87
|
208.8
|
233
|
268
|
301
|
Operating Margin
|
-
|
6.03%
|
11.82%
|
11.42%
|
11.94%
|
12.6%
|
Earnings before Tax (EBT)
|
-
|
89.2
|
210
|
-
|
-
|
-
|
Net income
|
91.23
|
68.5
|
163.7
|
-
|
-
|
-
|
Net margin
|
-
|
4.75%
|
9.27%
|
-
|
-
|
-
|
EPS
2 |
2.460
|
1.970
|
4.730
|
5.370
|
6.160
|
6.940
|
Free Cash Flow
1 |
-
|
-
|
234.2
|
216
|
207
|
250
|
FCF margin
|
-
|
-
|
13.26%
|
10.59%
|
9.22%
|
10.46%
|
FCF Conversion (EBITDA)
|
-
|
-
|
97.35%
|
82.13%
|
69.23%
|
75.08%
|
FCF Conversion (Net income)
|
-
|
-
|
143.05%
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
3.000
|
2.000
|
1.750
|
3.000
|
Announcement Date
|
2/28/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
334.4
|
329.5
|
349.9
|
429.3
|
393.7
|
-
|
436.9
|
527.9
|
454.5
|
505
|
514
|
567
|
514
|
EBITDA
1 |
25.8
|
20.1
|
25.4
|
40.8
|
44.4
|
-
|
71.2
|
71.3
|
51.74
|
65
|
76
|
70
|
62
|
EBIT
1 |
20.16
|
13.62
|
18.39
|
34.8
|
37.75
|
-
|
64.51
|
59.56
|
44.62
|
57
|
69
|
63
|
54
|
Operating Margin
|
6.03%
|
4.14%
|
5.26%
|
8.11%
|
9.59%
|
-
|
14.76%
|
11.28%
|
9.82%
|
11.29%
|
13.42%
|
11.11%
|
10.51%
|
Earnings before Tax (EBT)
1 |
19.9
|
13.3
|
17.9
|
38
|
36.9
|
-
|
67.5
|
59.1
|
44.7
|
57
|
70
|
64
|
55
|
Net income
1 |
15.13
|
10.1
|
14.27
|
28.2
|
29.27
|
36.8
|
53.38
|
44.29
|
35.44
|
45
|
54
|
50
|
43
|
Net margin
|
4.53%
|
3.06%
|
4.08%
|
6.57%
|
7.43%
|
-
|
12.22%
|
8.39%
|
7.8%
|
8.91%
|
10.51%
|
8.82%
|
8.37%
|
EPS
2 |
0.4400
|
0.2900
|
0.4200
|
0.8200
|
0.8500
|
1.060
|
1.560
|
1.260
|
-
|
1.310
|
1.580
|
1.440
|
1.240
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/13/22
|
8/26/22
|
11/17/22
|
2/28/23
|
5/12/23
|
8/31/23
|
11/16/23
|
2/27/24
|
5/22/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
257
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.069
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
234
|
216
|
207
|
250
|
ROE (net income / shareholders' equity)
|
-
|
-
|
77.2%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
21.9%
|
-
|
-
|
-
|
Assets
|
-
|
-
|
746.7
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
7.660
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/28/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +21.31% | 236M | | -.--% | 843M | | +0.79% | 682M | | +45.31% | 530M | | 0.00% | 153M | | +217.39% | 88.48M |
Health Food Stores
|